Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults ≥ 65 years of age: a Phase II, open-label study
Ruvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, Pierre Bourron, Marion Fournier, Tamala Mallett Moore, Aseem Pandey, Lucia Perez, Nessryne Sater, Anju Shrestha, Sophie Wague, Sandrine I Samson
doi: https://doi.org/10.1101/2021.10.29.21265248
Ruvim Izikson
1Sanofi Pasteur, Swiftwater, Pennsylvania, USA
Daniel Brune
2Accelerated Enrollment Solutions, Peoria, Illinois, USA
Jean-Sébastien Bolduc
3Sanofi Pasteur, Marcy l’Etoile, France
Pierre Bourron
4Sanofi Pasteur, Lyon, France
Marion Fournier
4Sanofi Pasteur, Lyon, France
Tamala Mallett Moore
1Sanofi Pasteur, Swiftwater, Pennsylvania, USA
Aseem Pandey
1Sanofi Pasteur, Swiftwater, Pennsylvania, USA
Lucia Perez
1Sanofi Pasteur, Swiftwater, Pennsylvania, USA
Nessryne Sater
3Sanofi Pasteur, Marcy l’Etoile, France
Anju Shrestha
1Sanofi Pasteur, Swiftwater, Pennsylvania, USA
Sophie Wague
4Sanofi Pasteur, Lyon, France
Sandrine I Samson
4Sanofi Pasteur, Lyon, France

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 29, 2021.
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults ≥ 65 years of age: a Phase II, open-label study
Ruvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, Pierre Bourron, Marion Fournier, Tamala Mallett Moore, Aseem Pandey, Lucia Perez, Nessryne Sater, Anju Shrestha, Sophie Wague, Sandrine I Samson
medRxiv 2021.10.29.21265248; doi: https://doi.org/10.1101/2021.10.29.21265248
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults ≥ 65 years of age: a Phase II, open-label study
Ruvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, Pierre Bourron, Marion Fournier, Tamala Mallett Moore, Aseem Pandey, Lucia Perez, Nessryne Sater, Anju Shrestha, Sophie Wague, Sandrine I Samson
medRxiv 2021.10.29.21265248; doi: https://doi.org/10.1101/2021.10.29.21265248
Subject Area
Subject Areas
- Addiction Medicine (240)
- Allergy and Immunology (521)
- Anesthesia (125)
- Cardiovascular Medicine (1419)
- Dermatology (158)
- Emergency Medicine (291)
- Epidemiology (10295)
- Gastroenterology (527)
- Genetic and Genomic Medicine (2629)
- Geriatric Medicine (254)
- Health Economics (497)
- Health Informatics (1733)
- Health Policy (789)
- Hematology (266)
- HIV/AIDS (565)
- Medical Education (273)
- Medical Ethics (83)
- Nephrology (289)
- Neurology (2461)
- Nursing (145)
- Nutrition (377)
- Oncology (1323)
- Ophthalmology (401)
- Orthopedics (146)
- Otolaryngology (237)
- Pain Medicine (168)
- Palliative Medicine (51)
- Pathology (343)
- Pediatrics (780)
- Primary Care Research (296)
- Public and Global Health (5007)
- Radiology and Imaging (893)
- Respiratory Medicine (681)
- Rheumatology (309)
- Sports Medicine (245)
- Surgery (298)
- Toxicology (45)
- Transplantation (140)
- Urology (108)